Latest News and Press Releases

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 6 January 2025) Immunocore Holdings plc...

ZyVersa looks forward to meeting with investors and potential collaborators at JPM 2025 to discuss our technology, pipeline, and development milestones.

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...

CASTLE ROCK, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- HEI Civil, a national heavy civil construction company, is pleased to announce the promotion of JP Morgan to Chief Operating Officer. Morgan...

SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...

SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...

JACKSONVILLE, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer, Joe Hinrichs, will address the 2024 JP Morgan Industrials Conference in New York...

Pacific General, announces the appointment of Pieter Wernick and John Romney as Senior Advisors to Pacific General’s Private Equity team.

SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...

Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.